All Posts: clinical trials
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Pressure to Endorse Use of Unproven Drugs for COVID-19 Threatens Public Confidence
WASHINGTON (April 16, 2020) — The widespread use of experimental treatments for COVID-19, including the antimalarial drugs chloroquine and hydroxychloroquine, represents “ill-advised and uncontrolled human experimentation with unproven treatments,” say two former FDA chief scientists. Furthermore, political pressure or advocacy for specific experimental treatments, such as that surrounding the issuance of an Emergency Use Authorization […]
Category: News Release
-
Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer
Category: GUMC Stories
-
Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among […]
Category: News Release
-
Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published
Category: News Release
-
Virtual Review of Cancer Clinical Trial Treatment Options Quicker Than Conventional Methods
Category: News Release
-
Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia
WASHINGTON (October 8, 2019) — Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson’s and Alzheimer’s disease. Lewy body dementia has similar symptoms to both Parkinson’s and Alzheimer’s diseases — some people […]
Category: News Release
-
The Right Place, the Right Time, the Right People, Thanks to Cancer Center Collaboration
Category: GUMC Stories
-
Georgetown Technique Using Urine Suggests Individualized Bladder Cancer Treatment Possible
Category: News Release
-
Clinical Trial for Men With Osteoporosis Now Open for Volunteers
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (June 4, 2019) — Enrollment in a clinical trial testing a new treatment for men with osteoporosis is now open at Georgetown University Medical Center. Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue (brittle bones) that makes bones more fragile and likely to […]
Category: News Release